Literature DB >> 31875227

How should we manage incidental meningiomas?

Farshad Nassiri1, Gelareh Zadeh1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 31875227      PMCID: PMC7032628          DOI: 10.1093/neuonc/noz237

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  15 in total

1.  Incidental findings on brain MRI in the general population.

Authors:  Meike W Vernooij; M Arfan Ikram; Hervé L Tanghe; Arnaud J P E Vincent; Albert Hofman; Gabriel P Krestin; Wiro J Niessen; Monique M B Breteler; Aad van der Lugt
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

2.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.

Authors:  Quinn T Ostrom; Haley Gittleman; Jordan Xu; Courtney Kromer; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2016-10-01       Impact factor: 12.300

3.  DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.

Authors:  Felix Sahm; Daniel Schrimpf; Damian Stichel; David T W Jones; Thomas Hielscher; Sebastian Schefzyk; Konstantin Okonechnikov; Christian Koelsche; David E Reuss; David Capper; Dominik Sturm; Hans-Georg Wirsching; Anna Sophie Berghoff; Peter Baumgarten; Annekathrin Kratz; Kristin Huang; Annika K Wefers; Volker Hovestadt; Martin Sill; Hayley P Ellis; Kathreena M Kurian; Ali Fuat Okuducu; Christine Jungk; Katharina Drueschler; Matthias Schick; Melanie Bewerunge-Hudler; Christian Mawrin; Marcel Seiz-Rosenhagen; Ralf Ketter; Matthias Simon; Manfred Westphal; Katrin Lamszus; Albert Becker; Arend Koch; Jens Schittenhelm; Elisabeth J Rushing; V Peter Collins; Stefanie Brehmer; Lukas Chavez; Michael Platten; Daniel Hänggi; Andreas Unterberg; Werner Paulus; Wolfgang Wick; Stefan M Pfister; Michel Mittelbronn; Matthias Preusser; Christel Herold-Mende; Michael Weller; Andreas von Deimling
Journal:  Lancet Oncol       Date:  2017-03-15       Impact factor: 41.316

4.  Challenges and opportunities in meningiomas: recommendations from the International Consortium on Meningiomas.

Authors:  Farshad Nassiri; Ghazaleh Tabatabai; Kenneth Aldape; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

5.  Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.

Authors:  Victoria E Clark; E Zeynep Erson-Omay; Akdes Serin; Jun Yin; Justin Cotney; Koray Ozduman; Timuçin Avşar; Jie Li; Phillip B Murray; Octavian Henegariu; Saliha Yilmaz; Jennifer Moliterno Günel; Geneive Carrión-Grant; Baran Yilmaz; Conor Grady; Bahattin Tanrikulu; Mehmet Bakircioğlu; Hande Kaymakçalan; Ahmet Okay Caglayan; Leman Sencar; Emre Ceyhun; A Fatih Atik; Yaşar Bayri; Hanwen Bai; Luis E Kolb; Ryan M Hebert; S Bulent Omay; Ketu Mishra-Gorur; Murim Choi; John D Overton; Eric C Holland; Shrikant Mane; Matthew W State; Kaya Bilgüvar; Joachim M Baehring; Philip H Gutin; Joseph M Piepmeier; Alexander Vortmeyer; Cameron W Brennan; M Necmettin Pamir; Türker Kiliç; Richard P Lifton; James P Noonan; Katsuhito Yasuno; Murat Günel
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

6.  Integrated genomic analyses of de novo pathways underlying atypical meningiomas.

Authors:  Akdes Serin Harmancı; Mark W Youngblood; Victoria E Clark; Süleyman Coşkun; Octavian Henegariu; Daniel Duran; E Zeynep Erson-Omay; Leon D Kaulen; Tong Ihn Lee; Brian J Abraham; Matthias Simon; Boris Krischek; Marco Timmer; Roland Goldbrunner; S Bülent Omay; Jacob Baranoski; Burçin Baran; Geneive Carrión-Grant; Hanwen Bai; Ketu Mishra-Gorur; Johannes Schramm; Jennifer Moliterno; Alexander O Vortmeyer; Kaya Bilgüvar; Katsuhito Yasuno; Richard A Young; Murat Günel
Journal:  Nat Commun       Date:  2017-02-14       Impact factor: 14.919

7.  Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes.

Authors:  Abdurrahman I Islim; Midhun Mohan; Richard D C Moon; Nisaharan Srikandarajah; Samantha J Mills; Andrew R Brodbelt; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2019-01-17       Impact factor: 4.130

8.  Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival.

Authors:  Olivier Morin; William C Chen; Farshad Nassiri; Matthew Susko; Stephen T Magill; Harish N Vasudevan; Ashley Wu; Martin Vallières; Efstathios D Gennatas; Gilmer Valdes; Melike Pekmezci; Paula Alcaide-Leon; Abrar Choudhury; Yannet Interian; Siavash Mortezavi; Kerem Turgutlu; Nancy Ann Oberheim Bush; Timothy D Solberg; Steve E Braunstein; Penny K Sneed; Arie Perry; Gelareh Zadeh; Michael W McDermott; Javier E Villanueva-Meyer; David R Raleigh
Journal:  Neurooncol Adv       Date:  2019-08-28

Review 9.  EANO guidelines for the diagnosis and treatment of meningiomas.

Authors:  Roland Goldbrunner; Giuseppe Minniti; Matthias Preusser; Michael D Jenkinson; Kita Sallabanda; Emmanuel Houdart; Andreas von Deimling; Pantelis Stavrinou; Florence Lefranc; Morten Lund-Johansen; Elizabeth Cohen-Jonathan Moyal; Dieta Brandsma; Roger Henriksson; Riccardo Soffietti; Michael Weller
Journal:  Lancet Oncol       Date:  2016-08-30       Impact factor: 41.316

10.  Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.

Authors:  Priscilla K Brastianos; Peleg M Horowitz; Sandro Santagata; Robert T Jones; Aaron McKenna; Gad Getz; Keith L Ligon; Emanuele Palescandolo; Paul Van Hummelen; Matthew D Ducar; Alina Raza; Ashwini Sunkavalli; Laura E Macconaill; Anat O Stemmer-Rachamimov; David N Louis; William C Hahn; Ian F Dunn; Rameen Beroukhim
Journal:  Nat Genet       Date:  2013-01-20       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.